Pyoderma gangrenosum is an uncommon inflammatory skin disease causing progressive, painful cutaneous ulceration. Systemic disorders are associated with approximately 50% of the cases; the most common disorders are inflammatory bowel disease, rheumatoid arthritis and the seronegative arthritides, hematological malignancies, and monoclonal gammopathies, most typically IgA. The bullous variant is often associated with myeloproliferative diseases1,2. Histologically, pyoderma gangrenosum is classified among the neutrophilic dermatoses, a group of cutaneous disorders characterized by a widespread, noninfectious, dermal neutrophilic inflammatory infiltrate. The histologic findings are variable and depend on the age of the lesion and the location of the biopsy. Although the histopathologic features are not diagnostic, a skin biopsy is necessary to rule out other causes of acute skin ulceration. The location of the biopsy is crucial in order to distinguish the lesion from other conditions, including the other neutrophilic dermatoses, infections, and vasculitis. The most fruitful yield comes from the violaceous edge of the lesion, rather than the center of the ulcer, which may show nonspecific secondary changes. A deep wedge biopsy including both the edge and a more central portion of the ulcer is most useful, and special stains for bacteria, mycobacteria, and fungi should be performed. Because the histologic features of pyoderma gangrenosum are nonspecific, the diagnosis is truly one of exclusion and is heavily reliant on clinical features and course. The absence of diagnostic laboratory tests or pathognomonic features and the fact that associated conditions may be undeclared put the onus on the treating physician to exclude other causes of skin ulceration and to identify any underlying disease. In one recent study, the frequency of misdiagnosis of pyoderma gangrenosum was 10%3. The condition most often presents on the legs as a rapidly expanding solitary ulcer with a violaceous, undermined border and a necrotic …